Valneva SE (VALN) Cash from Operations (2021 - 2026)
Valneva SE (VALN) posted Cash from Operations of 365272.64 for Q1 2026, up 98.82% sequentially from 30936784.49 in Q4 2025, and up 95.51% YoY from 186829.55 in Q1 2025.
Valneva SE (VALN) Cash from Operations (2021 - 2026) Analysis & Trends
Valneva SE has reported Cash from Operations for 6 years, with the latest figure at 365272.64 in Q1 2026.
- Quarterly Cash from Operations rose 95.51% year-over-year to 365272.64 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 52926597.59 (down 5.17% YoY) and the FY2025 annual result came in at 61570917.67, up 15.37% from the prior year.
- Cash from Operations advanced to 365272.64 in Q1 2026 per VALN's latest filing, from 30936784.49 in the prior quarter.
- Over five years, Cash from Operations peaked at 70380727182.66 in Q3 2023 and troughed at 70524304756.14 in Q2 2023.
- A 5-year average of 37088372.25 and a median of 30135890.08 in 2022 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 78512.01% in 2023, down 90987.76% in 2023.
- Over 5 years, Cash from Operations stood at 58064318.05 in 2022, then retreated by 23.83% to 71898608.48 in 2023, then jumped by 111.84% to 8514568.15 in 2024, then sank by 463.34% to 30936784.49 in 2025, then jumped by 98.82% to 365272.64 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 365272.64, 30936784.49, and 18644090.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | -15.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.61 Mn |
| Jun 30, 2026 | -15.61 Mn |
| Mar 31, 2026 | -365,272.64 |
| Mar 31, 2026 | -365,272.64 |
| Dec 31, 2025 | -30.94 Mn |
| Dec 31, 2025 | -30.94 Mn |
| Sep 30, 2025 | -18.64 Mn |
| Sep 30, 2025 | -18.64 Mn |
| Jun 30, 2025 | -2.98 Mn |
| Jun 30, 2025 | -2.98 Mn |
| Mar 31, 2025 | -8.14 Mn |
| Mar 31, 2025 | -8.14 Mn |
| Dec 31, 2024 | 8.51 Mn |
| Dec 31, 2024 | 8.51 Mn |
| Sep 30, 2024 | -11.02 Mn |
| Sep 30, 2024 | -11.02 Mn |
| Jun 30, 2024 | -39.68 Mn |
| Jun 30, 2024 | -39.68 Mn |
| Mar 31, 2024 | -30.75 Mn |
| Mar 31, 2024 | -30.75 Mn |